524494:BOM
IPCA Laboratories Ltd
₹1,909.35
arrow_downward
-0.22%(-4.30) 1H
15 Okt, 2:20:46 PTG GMT+5:30 · INR
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 524494...
Buka
₹1,871.50
Tinggi
₹1,929.50
Rendah
₹1,871.50
Permodalan Pasaran
484.24B
Purata volum
28.54K
Volum
5.32K
Dividen
0.31%
Dividen suku tahunan
₹1.50
Tarikh tanpa dividen
7 Ogo 2026
Nisbah H/P
36.98
tgi 52 mgu
₹2,039.30
rdh 52 mgu
₹1,252.95
EPS
₹51.63
Syer tertunggak
126.35J
Bilangan pekerja
17K
Buka
₹1,871.50
Tinggi
₹1,929.50
Rendah
₹1,871.50
Permodalan Pasaran
484.24B
Purata volum
28.54K
Volum
5.32K
Dividen
0.31%
Dividen suku tahunan
₹1.50
Tarikh tanpa dividen
7 Ogo 2026
Nisbah H/P
36.98
tgi 52 mgu
₹2,039.30
rdh 52 mgu
₹1,252.95
EPS
₹51.63
Syer tertunggak
126.35J
Bilangan pekerja
17K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Astro Awani
·
6 jam lalu
S&P 500: Wall Street market update | 15 October 2026
Invezz
·
2 hari lalu
Dow Jones dibuka 190 mata lebih tinggi, pelabur memerhati pendapatan bank dan inflasi
Invezz
·
2 hari lalu
Dow naik 198 mata, saham AS bercampur menjelang keputusan pendapatan
Invezz
·
1 hari lalu
Dow ditutup 170 mata lebih rendah ketika penjualan saham cip berterusan
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Perihal IPCA Laboratories Ltd